MedTrace Logo

Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire

NCT05191251 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3588

Last updated 2022-07-20

No results posted yet for this study

Summary

The diagnostic performance of the HEMSTOP (Hematoma, hEmorrhage, Menorrhagia, Surgery, Tooth extraction, Obstetrics, Parents) standardized questionnaire collected during the preoperative anesthesia consultation in order to detect a deficit in hemostasis associated with the risk of hemorrhage in pregnant women will be analyzed. The primary aim of the study is to assess the sensitivity and the specificity of the HEMSTOP questionnaire to identity patients with an abnormal first-line hemostasis test requiring further development by performing second-line hemostasis tests. The second aim of the study is to assess the sensitivity and specificity of the HEMSTOP questionnaire in predicting postpartum hemorrhage.

Conditions

  • Peripartum Period
  • Hemorrhage
  • HEMSTOP Questionnaire

Interventions

DIAGNOSTIC_TEST

HEMSTOP questionnaire

A HEMSTOP questionnaire is obtained during the anesthesia consultation.

Sponsors & Collaborators

  • Brugmann University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-13
Primary Completion
2022-06-10
Completion
2022-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05191251 on ClinicalTrials.gov